These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 31286142)

  • 1. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
    Kacher R; Lamazière A; Heck N; Kappes V; Mounier C; Despres G; Dembitskaya Y; Perrin E; Christaller W; Sasidharan Nair S; Messent V; Cartier N; Vanhoutte P; Venance L; Saudou F; Néri C; Caboche J; Betuing S
    Brain; 2019 Aug; 142(8):2432-2450. PubMed ID: 31286142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
    Boussicault L; Alves S; Lamazière A; Planques A; Heck N; Moumné L; Despres G; Bolte S; Hu A; Pagès C; Galvan L; Piguet F; Aubourg P; Cartier N; Caboche J; Betuing S
    Brain; 2016 Mar; 139(Pt 3):953-70. PubMed ID: 26912634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.
    Boussicault L; Kacher R; Lamazière A; Vanhoutte P; Caboche J; Betuing S; Potier MC
    Biochimie; 2018 Oct; 153():70-79. PubMed ID: 30107216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington's disease.
    Nóbrega C; Conceição A; Costa RG; Koppenol R; Sequeira RL; Nunes R; Carmo-Silva S; Marcelo A; Matos CA; Betuing S; Caboche J; Cartier N; Alves S
    BMC Res Notes; 2020 Apr; 13(1):210. PubMed ID: 32276655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum.
    Pinchaud K; Masson C; Dayre B; Mounier C; Gilles JF; Vanhoutte P; Caboche J; Betuing S
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy by proteasome activator, PA28γ, improves motor coordination and proteasome function in Huntington's disease YAC128 mice.
    Jeon J; Kim W; Jang J; Isacson O; Seo H
    Neuroscience; 2016 Jun; 324():20-8. PubMed ID: 26944602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of cholesterol metabolism in Huntington's disease.
    Leoni V; Caccia C
    Biochem Biophys Res Commun; 2014 Apr; 446(3):697-701. PubMed ID: 24525128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
    Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.
    Xie Y; Hayden MR; Xu B
    J Neurosci; 2010 Nov; 30(44):14708-18. PubMed ID: 21048129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered anterograde axonal transport of mitochondria in cultured striatal neurons of a knock-in mouse model of Huntington's disease.
    Wu C; Yin H; Fu S; Yoo H; Zhang M; Park H
    Biochem Biophys Res Commun; 2024 Jan; 691():149246. PubMed ID: 38029540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
    Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
    Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
    Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
    J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.
    Liu Y; Hettinger CL; Zhang D; Rezvani K; Wang X; Wang H
    J Neurochem; 2014 May; 129(3):539-47. PubMed ID: 24383989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
    Canals JM; Pineda JR; Torres-Peraza JF; Bosch M; Martín-Ibañez R; Muñoz MT; Mengod G; Ernfors P; Alberch J
    J Neurosci; 2004 Sep; 24(35):7727-39. PubMed ID: 15342740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
    McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
    Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond.
    Moutinho M; Nunes MJ; Rodrigues E
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1911-1920. PubMed ID: 27663182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes.
    Birolini G; Verlengia G; Talpo F; Maniezzi C; Zentilin L; Giacca M; Conforti P; Cordiglieri C; Caccia C; Leoni V; Taroni F; Biella G; Simonato M; Cattaneo E; Valenza M
    Brain; 2021 Nov; 144(10):3175-3190. PubMed ID: 33974044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.